|
Vaccine/Therapy Name
|
Type
|
Countries
|
Manufacturer
|
|
Ad5-nCoV (Convidecia™)
|
Single-dose recombinant viral vector vaccine
|
add_circle_outline
remove_circle_outline
|
Beijing Institute of Biotechnology of the Academy of Military Medical Sciences, CanSino Biologics Inc.
|
|
|
|
AZD-1222
|
Two-dose recombinant viral vector vaccine
|
add_circle_outline
remove_circle_outline
|
AstraZeneca plc, University of Oxford
|
|
|
|
Bamlanivimab (LY-3819253, LY-CoV555)
|
MAb
|
add_circle_outline
remove_circle_outline
|
Abcellera Biologics Inc., Eli Lilly and Co.
|
|
|
|
Baricitinib (OLUMIANT®)
|
Janus kinase inhibitor
|
add_circle_outline
remove_circle_outline
|
Abcellera Biologics Inc., Eli Lilly and Co.
|
|
|
|
BBIBP-CorV
|
Two-dose inactivated vaccine
|
add_circle_outline
remove_circle_outline
|
Beijing Institute of Biological Products Co. Ltd, Henan Provincial Center for Disease Control and Prevention
|
|
|
|
Casirivimab and imdevimab
|
MAb
|
add_circle_outline
remove_circle_outline
|
Regeneron Pharmaceuticals Inc., Roche
|
|
|
|
CoronaVac
|
Two-dose inactivated vaccine
|
add_circle_outline
remove_circle_outline
|
Bio Farma, Dynavax Technologies, Instituto Butantan, Sinovac Biotech Ltd.
|
|
|
|
COVAXIN®
|
Two-dose inactivated vaccine
|
add_circle_outline
remove_circle_outline
|
Bharat Biotech International, Ocugen Inc.
|
|
|
|
CoviVac
|
Two-dose inactivated vaccine
|
add_circle_outline
remove_circle_outline
|
Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Science
|
|
|
|
Dexamethasone phosphate (DEXAVAN)
|
Corticosteroid
|
add_circle_outline
remove_circle_outline
|
Bausch Health, Oxford University
|
|
|
|
EpiVacCorona
|
Two-dose synthetic peptide
|
add_circle_outline
remove_circle_outline
|
State Research Center of Virology and Biotechnology VECTOR
|
|
|
|
Etesevimab (LY-CoV016)
|
MAb
|
add_circle_outline
remove_circle_outline
|
Abcellera Biologics Inc., Eli Lilly and Co., Shanghai Junshi Biosciences Co. Ltd.
|
|
|
|
Favipiravir (Reeqonus™, Avigan®)
|
Broad-spectrum antiviral; Viral RNA-dependent, RNA polymerase inhibitor
|
add_circle_outline
remove_circle_outline
|
Appili Therapeutics, Dr. Reddy's Laboratories Ltd., Fujifilm Holdings, Fujifilm Toyama Chemical Co. Ltd., Genentech, Glenmark Pharmaceuticals Ltd., Medivector Inc., Sihuan Pharmaceutical Holdings Group, Zhejiang Hisun Pharmaceutical Co. Ltd.
|
|
|
|
Gam-COVID-Vac
|
Two-dose recombinant viral vector vaccine
|
add_circle_outline
remove_circle_outline
|
Gamaleya Research Institute, Sputnik V
|
|
|
|
JNJ-78436735 (Ad26.COV2-S)
|
Single-dose recombinant viral vector vaccine
|
add_circle_outline
remove_circle_outline
|
Biomedical Advanced Research and Development Authority (BARDA), Catalent, Emergent Biosolutions®, Grand River Aseptic Manufacturing, Johnson & Johnson
|
|
|
|
mRNA-1273 (TAK-919; elasomeran; SPIKEVAC™)
|
Two-dose, lipid nanoparticle RNA vaccine
|
add_circle_outline
remove_circle_outline
|
Catalent, Ginkgo Bioworks, Moderna Therapeutics, Recipharm, Takeda Pharmaceutical Co. Ltd.
|
|
|
|
Regdanvimab (Regkirona; CT-P59)
|
MAb
|
add_circle_outline
remove_circle_outline
|
Celltrion
|
|
|
|
Remdesivir (VEKLURY®)
|
Broad-spectrum antiviral; Viral RNA-dependent, RNA polymerase inhibitor
|
add_circle_outline
remove_circle_outline
|
Cipla Limited, Dr. Reddy's Laboratories Ltd., Gilead Sciences Inc., Hetero
|
|
|
|
Sotrovimab (GSK4182136, VIR-7831, VIR-7832)
|
MAb
|
add_circle_outline
remove_circle_outline
|
Biogen Inc., GlaxoSmithKline plc, National Institute of Allergy and Infectious Diseases (NIAID), Samsung Biologics, Vir Biotechnology, Wuxi Biologics, Xencor Inc.
|
|
|
|
Tixagevimab and cilgavimab (AZD-7442; combination of AZD-8895 and AZD-1061; Evusheld)
|
MAb
|
add_circle_outline
remove_circle_outline
|
AstraZeneca plc
|
|
|
|
Tocilizumab (Actemra; Roactemra)
|
MAb
|
add_circle_outline
remove_circle_outline
|
Chugai, Genentech
|
|
|
|
Tozinameran (BNT-162b2, COMIRNATY®)
|
Two-dose, lipid nanoparticle RNA vaccine
|
add_circle_outline
remove_circle_outline
|
BioNTech SE, Comirnaty, Fosun Pharma, Pfizer Inc.
|
|
|
|
ZF2001 (RBD-dimer, Zifivax)
|
Three-dose protein subunit
|
add_circle_outline
remove_circle_outline
|
Anhui Zhifei Longcom Biopharmaceutical Co. Ltd., Chinese Academy of Sciences
|
|
|
|
ZyCov-D
|
Three-dose DNA
|
add_circle_outline
remove_circle_outline
|
Zydus Cadila Healthcare Ltd.
|
|
|
